April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Evaluation Of Fluocinolone Acetonide Implant (RetisertTm) Dislocation During Implant Removal/Exchange Surgery
Author Affiliations & Notes
  • Benjamin P. Nicholson
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio
  • Rishi P. Singh
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio
  • Jonathan E. Sears
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio
  • Careen Y. Lowder
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio
  • Peter K. Kaiser
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio
  • Footnotes
    Commercial Relationships  Benjamin P. Nicholson, None; Rishi P. Singh, None; Jonathan E. Sears, None; Careen Y. Lowder, None; Peter K. Kaiser, Consultant, Bausch & Lomb (C)
  • Footnotes
    Support  Grant support: Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 529. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Benjamin P. Nicholson, Rishi P. Singh, Jonathan E. Sears, Careen Y. Lowder, Peter K. Kaiser; Evaluation Of Fluocinolone Acetonide Implant (RetisertTm) Dislocation During Implant Removal/Exchange Surgery. Invest. Ophthalmol. Vis. Sci. 2011;52(14):529.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To characterize the phenomenon of dissociation of the two components of a RetisertTM(Bausch and Lomb) implant during removal and/or exchange procedures and to evaluate patient outcomes after these events.

Methods: : Retrospective review of 27 consecutive RetisertTM exchange or removal surgeries between 2001 and 2010 at Cole Eye Institute. All patients had received the implant as a treatment for non-infectious uveitis. Pre- and post-operative characteristics including visual acuity, intraocular pressure, underlying diagnoses and comorbidities, and additional medical and surgical treatments were analyzed. Operative reports were reviewed to characterize the effects of intraoperative implant dissociation.

Results: : Twenty-seven RetisertTM exchange or removal surgeries were performed by three surgeons in twenty eyes of 19 patients. Of these 27 procedures, dissociation of the implant strut from the drug-containing cup occurred in 11 eyes (40.7%). Retrieval of the dislocated cup led to intraoperative complications including posterior retinal tear (n=1) and limited suprachoroidal hemorrhage (n=1). The length of time that the implant had been in the eye correlated significantly with cup dislocation. Dissociated implants had been in the eye a mean 47.4 months, whereas intact implants had been in the eye a mean 32.5 months (P=0.0032). Implant dissociation did not correlate with surgeon experience. Eyes that had implant dissociation did not require additional surgeries, and they had similar post-operative visual acuity outcomes as eyes that did not have implant dissociation. There was no long- or short-term vision loss attributed to implant dissociation.

Conclusions: : RetisertTM implant dissociation is a common occurrence in RetisertTM exchange procedures, and this event could in theory lead to serious adverse events. The longer an implant has been in the eye, the greater the tendency toward dissociation. Preparation for this complication should be contemplated in any implant removal/exchange procedure.

Keywords: vitreoretinal surgery • uveitis-clinical/animal model 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×